Who may be most likely to benefit from repetitive transcranial magnetic stimulation (rTMS)?
Even though repetitive transcranial magnetic stimulation (rTMS) is largely effective at treating depression even for those who do not respond to antidepressants, there is still a fraction of individuals who do not improve with rTMS. Predicting who may respond best to rTMS may help clinicians and patients make better choices as to what treatments to pursue, with the ultimate hope to better treat depression. Trevizol et al. (2020) used data from a clinical trial run by the NINET Lab at UBC called THREE-D to determine if there are characteristics that can help predict whether someone would benefit from rTMS.